Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01540695 · ClinicalTrials.gov registry record
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology
A clinical trial of Squamous Cell Carcinoma and Basal Cell Carcinoma, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 180
- Enrollment target
- 1
- Study location
NCT01540695 is a study of Squamous Cell Carcinoma and Basal Cell Carcinoma that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 180 participants, above the 100-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (80% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01540695, a study of Squamous Cell Carcinoma and Basal Cell Carcinoma, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective study of 60 slides of basal and squamous cell carcinomas of the skin aims to determine whether: 1. The process of cryofixation prior to generating formalin fixed paraffin embedded (FFPE) H\&E sections alters the histology in skin tumor specimens. 2. Which specific histologic parameters are altered between previously cryofixed versus routine FFPE sections. Histologic observations will be recorded by two dermatopathologists and two Mohs surgeons and statistically analyzed.
Conditions Studied
Study Locations (1)
Pennsylvania
- Abramsonc Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01540695
The ClinicalTrials.gov registry entry for NCT01540695 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 100-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (80% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT01540695 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01540695 about?
NCT01540695 is a clinical study titled "Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology". This prospective study of 60 slides of basal and squamous cell carcinomas of the skin aims to determine whether: 1. The process of cryofixation prior to generating formalin fixed paraffin embedded (FFPE) H\&E sections alters the histology in skin tumor specimens. 2. Which specific histologic parame...
What is the current status of trial NCT01540695?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2012-02. Estimated completion is 2013-01.
What conditions does trial NCT01540695 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Basal Cell Carcinoma.
Who is sponsoring clinical trial NCT01540695?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01540695 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
RECRUITING · Phase 2
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Toripalimab With Chemotherapy for Sinus Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.